首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1593510

新生儿筛检市场规模、份额和成长分析（按产品、技术、测试类型和地区）：产业预测（2024-2031）

Newborn Screening Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type (Dry Blood Spot Test, CCHD), By Region - Industry Forecast 2024-2031

出版日期: 2024年11月15日 | 出版商:

SkyQuest | 英文 177 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023年，全球新生儿筛检市场规模为12.5亿美元，从2024年的13.4亿美元成长到2031年的21.2亿美元，在预测期间（2024-2031年）预计复合年增长率为6.8。。

出生率的上升、婴幼儿先天性疾病的增加、消费者意识的提高以及政府的支持措施共同为新生儿筛检产业创造了强劲的成长轨迹。世界卫生组织（WHO）指出，先天性疾病导致约24万名新生儿在出生后28天内死亡，约17万名1个月至5岁儿童死亡，强调了情况的严重性。具体而言，印度先天性代谢缺陷的盛行率在 2% 至 7.8% 之间，每 1,000 名新生儿中就有 2.1 人患有先天性甲状腺机能低下症，随着检测变得更加广泛，印度将成为一个巨大的市场。随着更有效率、更有效的方法的出现，筛检方法的技术进步进一步推动市场成长。此外，曼尼托巴省于 2022 年 6 月启动的扩大新生儿筛检以纳入脊髓性肌肉萎缩症的倡议等政府主导的计划将加强筛检领域，鼓励广泛采用筛检通讯协定，并在促进实施方面发挥作用。随着对先天性疾病了解的加深以及早期检测对社会变得更加重要，预计到 2031 年，新生儿筛检市场将大幅扩大。这些因素集中为新生儿筛检的创新和投资创造了有利的环境，使其成为医疗保健相关人员关注的关键领域。

北美（按产品、测试、技术、最终用户）
- 美国
- 加拿大
欧洲（按产品、测试、技术、最终用户）
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家
亚太地区（依产品、测试、技术、最终用户）
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲（按产品、测试、技术、最终用户）
- 巴西
- 其他拉丁美洲
中东/非洲（按产品、测试、技术、最终用户）
- 波湾合作理事会(GCC) 国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 年比收益成长（YoY）比较（2021-2023）

主要企业简介

Masimo Corp.
Covidien Plc
AB Sciex LLC
Natus Medical Inc.
Agilent Technologies Inc.
PerkinElmer Inc.
GE Healthcare
Bio-Rad Laboratories Inc.
Trivitron Healthcare
Medtronic Inc.
Rady Children's Institute for Genomic Medicine
GE Lifesciences
Waters Corporation
Danaher Corporation
Thermo Fisher Scientific Inc.
ZIVAK TECHNOLOGIES
CAMAG
OTODYNAMICS
ZENTECH
VIVOSONIC

结论和建议

简介目录

Product Code: SQMIG35E2050

Global Newborn Screening Market size was valued at USD 1.25 Billion in 2023 and is poised to grow from USD 1.34 Billion in 2024 to USD 2.12 Billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Market insights reveal a robust growth trajectory for the newborn screening sector, driven by a combination of rising birth rates, increasing congenital illnesses among infants, heightened consumer awareness, and supportive government initiatives. The World Health Organization highlights the gravity of the situation, noting that congenital disorders are responsible for approximately 240,000 neonatal deaths annually within the first 28 days of birth, and around 170,000 child deaths from one month to five years old. Specifically, the prevalence of in-born metabolic disorders in India ranges from 2% to 7.8%, with congenital hypothyroidism affecting 2.1 out of every 1,000 newborns, indicating a significant market potential as testing becomes more prevalent. Technological advancements in screening methodologies are further propelling market growth, as more efficient and effective techniques become available. Additionally, government-led programs, such as Manitoba's initiative launched in June 2022 to expand its newborn screening to include spinal muscular atrophy, serve to enhance the screening landscape, encouraging wider adoption and implementation of screening protocols. As the understanding of congenital disorders deepens and societal emphasis on early detection intensifies, the newborn screening market is expected to see considerable expansion through 2031. The convergence of these elements establishes a favorable climate for innovation and investment in newborn screening, positioning it as a critical area of focus for stakeholders in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Newborn Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Newborn Screening Market Segmental Analysis

Global Newborn Screening Market is segmented by Product, Test, technology, end user and region. Based on Product, the market is segmented into Consumables, Instruments, Hearing screening instruments, Pulse oximeters. Based on Test, the market is segmented into Dry blood spot tests, Hearing screening tests, CCHD screening tests. Based on technology, the market is segmented into Immune assays & enzymatic assays, Tandem mass spectrometry, Molecular assays, Hearing screening technologies, Pulse oximetry, Other Technologies. Based on end user, the market is segmented into Clinical Laboratories, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Newborn Screening Market

The rising prevalence of congenital abnormalities is a key market driver for the Global Newborn Screening market, fueling demand for early diagnostic solutions. Conditions such as genetic disorders, hearing impairments, and metabolic disorders emphasize the need for prompt identification and intervention, which can significantly enhance treatment outcomes and the quality of life for affected neonates. As medical technology advances and understanding of the benefits of early diagnosis deepens, the importance of comprehensive screening programs becomes increasingly evident. Additionally, heightened awareness of congenital disorders and focused initiatives to safeguard newborn health are encouraging the adoption of thorough screening techniques, thus bolstering market growth.

Restraints in the Global Newborn Screening Market

The high cost of newborn screening tests presents a significant market restraint, particularly impacting low- and middle-income countries. These financial barriers restrict access to essential screening, preventing families from benefiting from potentially lifesaving treatments. As a result, the delay in detection and intervention can severely compromise the health outcomes of affected neonates. Furthermore, the existing disparity in access to these critical tests highlights the urgent need for more affordable screening options and support networks that promote equitable early diagnostic services. Addressing this monetary limitation is crucial for advancing global infant health and ensuring all newborns receive adequate care.

Market Trends of the Global Newborn Screening Market

The Global Newborn Screening market is witnessing a significant trend towards advanced genetic testing integration, characterized by the adoption of Whole Genome Sequencing (WGS) and Next-Generation Sequencing (NGS). These innovative technologies facilitate the precise identification of a broader range of genetic disorders, including complex and rare conditions often overlooked by traditional methods. As the costs associated with genetic testing continue to decline, the availability of comprehensive screening panels is expanding, enabling earlier and more accurate detection of genetic abnormalities. This evolution not only enhances the efficacy of newborn screening programs but also improves clinical outcomes, driving demand and growth within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
Market Attractiveness Index

Global Newborn Screening Market Size by Product & CAGR (2024-2031)

Market Overview
Consumables
Instruments
Hearing screening instruments
Pulse oximeters

Global Newborn Screening Market Size by Test & CAGR (2024-2031)

Market Overview
Dry blood spot tests
Hearing screening tests
CCHD screening tests

Global Newborn Screening Market Size by Technology & CAGR (2024-2031)

Market Overview
Immune assays & enzymatic assays
Tandem mass spectrometry
Molecular assays
Hearing screening technologies
Pulse oximetry
Other Technologies

Global Newborn Screening Market Size by End User & CAGR (2024-2031)

Market Overview
Clinical Laboratories
Hospitals

Global Newborn Screening Market Size & CAGR (2024-2031)

North America, (Product, Test, Technology, End User)
- US
- Canada
Europe, (Product, Test, Technology, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Test, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Test, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Test, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Masimo Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covidien Plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB Sciex LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rady Children's Institute for Genomic Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZIVAK TECHNOLOGIES
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CAMAG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OTODYNAMICS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZENTECH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VIVOSONIC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments